Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DRKS00000663Phase 4Completed
Phase 4, open-label, single-arm trial of propofol and remifentanil, sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Nociceptive and antinociceptive responses under anesthesia. Started Dec 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on DRKS00000663.